Gene Polymorphism Study of Normal Individual Inflammasome Genes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2013-02-28

Study Completion Date

2014-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is intended to collect blood from healthy individuals to investigate whether variations in immune-related (inflammasome) genes affect how the immune cells found in the blood can help fight infections and prevent diseases.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Immunological Characterization of Blood of Normal Individuals

NCT01386892

Heathly Volunteers

COMPLETED

Investigation of Immune Disorders and Deficiencies

NCT01981785

Primary Immune Deficiencies Autoimmune Diseases Inflammatory Diseases +2 more

UNKNOWN

Genetic & Environmental Determinants Of Immune Phenotype Variance: A Longitudinal Assessment

NCT05381857

Healthy Subjects

COMPLETED

Immunomodulatory Effects of Fasting in Healthy Adults

NCT05104502

Fasting

RECRUITING NA

Inflammation and the Host Response to Injury (In Healthy Volunteers)

NCT00820989

Immune System

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Individuals

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Blood Draw

Normal healthy individuals will be consented and their blood drawn at the time of their visit.

Blood Draw

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood Draw

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Healthy with no chronic or acute illnesses, or taking medication which in the opinion of the PI would impact the analyses being conducted.
2. At least 18 years or older.
3. Are capable of reading, understanding and providing written informed consent.

Exclusion Criteria

1. Non-English speaking.
2. Individuals under 18 years old.
3. Woman who believe they are or may be pregnant. (Based on self reporting. Pregnancy testing will not be conducted for the purposes of this study)
4. Individuals experiencing acute or chronic illnesses which in the opinion of the PI would impact the analyses being conducted.
5. Currently taking prescription or over the counter medication which in the opinion of the PI would impact the analyses being conducted.
6. Individual has donated blood more than twice in the last week or the amount to be drawn will exceed the maximum allowance in the last 8 weeks.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes